MSH6 and gastric intestinal type adenocarcinoma: Of the 19 SNADETs, two showed deficient MMR; one was a gastric-type adenocarcinoma that showed loss of MSH2 and MSH6, and the other was an intestinal-type adenocarcinoma that showed loss of MLH1 and PMS2 (Figure 3).